| Mapping the hallmarks of lung adenocarcinoma with massively parallel sequencing M Imielinski, AH Berger, PS Hammerman, B Hernandez, TJ Pugh, ... Cell 150 (6), 1107-1120, 2012 | 2015 | 2012 |
| Integrative genome analyses identify key somatic driver mutations of small-cell lung cancer M Peifer, L Fernández-Cuesta, ML Sos, J George, D Seidel, LH Kasper, ... Nature genetics 44 (10), 1104-1110, 2012 | 1498 | 2012 |
| Frequent and focal FGFR1 amplification associates with therapeutically tractable FGFR1 dependency in squamous cell lung cancer J Weiss, ML Sos, D Seidel, M Peifer, T Zander, JM Heuckmann, RT Ullrich, ... Science translational medicine 2 (62), 62ra93-62ra93, 2010 | 1008 | 2010 |
| Mutations in the DDR2 Kinase Gene Identify a Novel Therapeutic Target in Squamous Cell Lung Cancer PS Hammerman, ML Sos, AH Ramos, C Xu, A Dutt, W Zhou, LE Brace, ... Cancer discovery 1 (1), 78-89, 2011 | 586 | 2011 |
| Extracorporeal membrane oxygenation: evolving epidemiology and mortality C Karagiannidis, D Brodie, S Strassmann, E Stoelben, A Philipp, T Bein, ... Intensive care medicine 42, 889-896, 2016 | 468 | 2016 |
| Therapeutic vaccination with TG4010 and first-line chemotherapy in advanced non-small-cell lung cancer: a controlled phase 2B trial E Quoix, R Ramlau, V Westeel, Z Papai, A Madroszyk, A Riviere, ... The lancet oncology 12 (12), 1125-1133, 2011 | 330 | 2011 |
| Frequent mutations in chromatin-remodelling genes in pulmonary carcinoids L Fernandez-Cuesta, M Peifer, X Lu, R Sun, L Ozretić, D Seidel, T Zander, ... Nature communications 5 (1), 3518, 2014 | 299 | 2014 |
| CD74–NRG1 Fusions in Lung Adenocarcinoma L Fernandez-Cuesta, D Plenker, H Osada, R Sun, R Menon, F Leenders, ... Cancer discovery 4 (4), 415-422, 2014 | 288 | 2014 |
| Impact of [18F]FDG-PET on the primary staging of small-cell lung cancer I Brink, T Schumacher, M Mix, S Ruhland, E Stoelben, W Digel, M Henke, ... European journal of nuclear medicine and molecular imaging 31, 1614-1620, 2004 | 277 | 2004 |
| Comparison of morbidity, 30-day mortality, and long-term survival after pneumonectomy and sleeve lobectomy for non–small cell lung carcinoma C Ludwig, E Stoelben, M Olschewski, J Hasse The Annals of thoracic surgery 79 (3), 968-973, 2005 | 258 | 2005 |
| Prevention, diagnosis, therapy, and follow-up of lung cancer G Goeckenjan, H Sitter, M Thomas, D Branscheid, M Flentje, F Griesinger, ... Pneumologie 65 (01), 39-59, 2011 | 233 | 2011 |
| PubMed results G Goeckenjan, H Sitter, M Thomas, D Branscheid, M Flentje, F Griesinger, ... Pneumologie 65 (8), e51-e75, 2011 | 218 | 2011 |
| Replication of lung cancer susceptibility loci at chromosomes 15q25, 5p15, and 6p21: a pooled analysis from the International Lung Cancer Consortium T Truong, RJ Hung, CI Amos, X Wu, H Bickeböller, A Rosenberger, ... Journal of the National Cancer Institute 102 (13), 959-971, 2010 | 215 | 2010 |
| Early Prediction of Nonprogression in Advanced Non–Small-Cell Lung Cancer Treated With Erlotinib By Using [18F]Fluorodeoxyglucose and [18F]Fluorothymidine … T Zander, M Scheffler, L Nogova, C Kobe, W Engel-Riedel, M Hellmich, ... Journal of Clinical Oncology 29 (13), 1701-1708, 2011 | 201 | 2011 |
| Newcastle disease virus-infected intact autologous tumor cell vaccine for adjuvant active specific immunotherapy of resected colorectal carcinoma. D Ockert, V Schirrmacher, N Beck, E Stoelben, T Ahlert, J Flechtenmacher, ... Clinical cancer research: an official journal of the American Association …, 1996 | 196 | 1996 |
| MET Amplification Status in Therapy-Naïve Adeno- and Squamous Cell Carcinomas of the Lung HU Schildhaus, AM Schultheis, J Rüschoff, E Binot, S Merkelbach-Bruse, ... Clinical Cancer Research 21 (4), 907-915, 2015 | 190 | 2015 |
| Frequency of local recurrence following segmentectomy of stage IA non-small cell lung cancer is influenced by segment localisation and width of resection margins—implications … W Sienel, C Stremmel, A Kirschbaum, L Hinterberger, E Stoelben, ... European journal of cardio-thoracic surgery 31 (3), 522-528, 2007 | 174 | 2007 |
| PIK3CA mutations in non-small cell lung cancer (NSCLC): genetic heterogeneity, prognostic impact and incidence of prior malignancies M Scheffler, M Bos, M Gardizi, K König, S Michels, J Fassunke, C Heydt, ... Oncotarget 6 (2), 1315, 2015 | 150 | 2015 |
| Definition of a fluorescence in-situ hybridization score identifies high-and low-level FGFR1 amplification types in squamous cell lung cancer HU Schildhaus, LC Heukamp, S Merkelbach-Bruse, K Riesner, K Schmitz, ... Modern pathology 25 (11), 1473-1480, 2012 | 147 | 2012 |
| Prävention, Diagnostik, Therapie und Nachsorge des Lungenkarzinoms G Goeckenjan, H Sitter, M Thomas, D Branscheid, M Flentje, F Griesinger, ... Pneumologie 64 (S 02), e1-e164, 2010 | 145 | 2010 |
